Ability of Patients to Distinguish Among Cardiac Genomic Variant Subclassifications
- 1 June 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 11 (6) , e001975
Abstract
BACKGROUND: Clinical genetic testing for heritable cardiovascular disease has become a widely used tool to aid in the management of patients and their families. A 5-category variant classification system is commonly used for genetic test results, but some laboratories further subclassify variants of uncertain significance. How and whether patients perceive differences among the variant categories or subclassifications of variants of uncertain significance is unknown. METHODS: We tested whether participants perceived differences in genetic variant subclassifications on outcomes including risk comprehension, risk perception, worry, perceived uncertainty, and intentions. Order-randomized hypothetical cardiovascular genetic results were given to 289 participants enrolled in a genome sequencing study. Three categories of variants were presented to participants: variants of uncertain significance, possibly pathogenic, and likely pathogenic. Responses to the first variant presented were analyzed in a between-groups analysis, and responses to all 3 variants were analyzed in a within-groups analysis. RESULTS: When presented with all 3 results, participants distinguished among the subclassifications on all outcomes (P<0.001). When given only a possibly pathogenic result, their risk perceptions were similar to those of variants of uncertain significance, but they were more worried and intended to behave as if they had received a likely pathogenic result. Individuals depended more on their affective responses such as worry when they received only one result (P<0.05). CONCLUSIONS: Participants are better able to distinguish pathogenicity subclassifications when presented with multiple categories. Individuals who receive a single uncertain result in a cardiovascular disease gene may benefit from interventions to decrease worry, calibrate risk perceptions, and motivate variant-appropriate behaviors.Keywords
This publication has 20 references indexed in Scilit:
- Diagnostic Clinical Genome and Exome SequencingNew England Journal of Medicine, 2014
- The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineTrials, 2014
- Worry and Risk Perceptions as Independent and Interacting Predictors of Health Protective BehaviorsJournal of Health Communication, 2013
- Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq studyEuropean Journal of Human Genetics, 2012
- The ClinSeq Project: Piloting large-scale genome sequencing for research in genomic medicineGenome Research, 2009
- Receiving inconclusive genetic test results: An interpretive description of the BRCA1/2 experienceResearch in Nursing & Health, 2008
- A systematic review of perceived risks, psychological and behavioral impacts of genetic testingGenetics in Medicine, 2008
- Clinical Interpretation and Recommendations for Patients with a Variant of Uncertain Significance in BRCA1 or BRCA2 : A Survey of Genetic Counseling PracticeGenetic Testing, 2002
- The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Journal of Personality and Social Psychology, 1986
- The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Journal of Personality and Social Psychology, 1986